Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Revive Therapeutics Ltd C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is... see more

CSE:RVV - Post Discussion

Revive Therapeutics Ltd > $RVV $RVVTF - Nice post from RioDad - iHub
View:
Post by cool888 on Feb 10, 2021 4:11pm

$RVV $RVVTF - Nice post from RioDad - iHub

I appreciate that Medicine. I got land blasted in December and put on “ ignore “ by a few here when I told people that initial data was never coming.

I know many on this board play the OTC like it’s Fantasy Football (or hockey for our Canadian friends), watching it minute by minute. I admit, I’ve got enough shares that I loose or gain a lot of money with each penny movement. But, I’m calm. Why?

Maybe I have a better handle on my emotions, or I don’t have attention deficit disorder, or maybe it’s because:-
- Pharm Olam has a wonderful reputation on trial study performance.
- Prior to the trial, Dr. Kelly McKee was enthusiastic about the Bucillamine hypothesis with regards to Covid.
- The trial itself is considered a Gold Standard, and any data released before all the data is in, would actually be bad news.
- There are indications of positive trial results, with out the data.
1) Frank’s comments in PR prior to Christmas
2) Adding sites in January
3) Funding from large investors, which sets the new floor in share price until news does break.
4) Hiring Research Doctor, in Fahy, that has overseen a Thiol Donor study.

I’ve always said trust the science, and the UCSF study was more encouraging than I had ever hoped for.

Good news is coming and the market is larger than just North America.
Comment by theprovincial on Feb 10, 2021 4:26pm
Excellent Post Cool888, I thoroughly enjoy reading through the information you consistently bring forward. 
Comment by 1ottrunner on Feb 10, 2021 4:39pm
I don't recall you saying that data wasn't coming, although considereding RVVs record for not posting trial data that is a possiblility. I do recall you saying you would never post here again, be a man and stand corrected, you may be able to look at yourself in the mirror with a little pride. There do appear to be a number of positive scenarios to look forward to, we shall see how that ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities